130 related articles for article (PubMed ID: 9869869)
1. Tolerance induction for islet transplantation.
Exner BG; Fowler K; Ildstad ST
Ann Transplant; 1997; 2(3):77-80. PubMed ID: 9869869
[TBL] [Abstract][Full Text] [Related]
2. Impact of bone marrow transplantation on type I diabetes.
Domenick MA; Ildstad ST
World J Surg; 2001 Apr; 25(4):474-80. PubMed ID: 11344401
[TBL] [Abstract][Full Text] [Related]
3. Mesenchymal stem cells facilitate the induction of mixed hematopoietic chimerism and islet allograft tolerance without GVHD in the rat.
Itakura S; Asari S; Rawson J; Ito T; Todorov I; Liu CP; Sasaki N; Kandeel F; Mullen Y
Am J Transplant; 2007 Feb; 7(2):336-46. PubMed ID: 17283484
[TBL] [Abstract][Full Text] [Related]
4. Chimerism and tolerance: from freemartin cattle and neonatal mice to humans.
Jankowski RA; Ildstad ST
Hum Immunol; 1997 Feb; 52(2):155-61. PubMed ID: 9077564
[TBL] [Abstract][Full Text] [Related]
5. A substantial level of donor hematopoietic chimerism is required to protect donor-specific islet grafts in diabetic NOD mice.
Guo Z; Wu T; Sozen H; Pan Y; Heuss N; Kalscheuer H; Sutherland DE; Blazar BR; Hering BJ
Transplantation; 2003 Apr; 75(7):909-15. PubMed ID: 12698073
[TBL] [Abstract][Full Text] [Related]
6. Mesenchymal stem cells enhance the induction of mixed chimerism and tolerance to rat hind-limb allografts after bone marrow transplantation.
Pan H; Zhao K; Wang L; Zheng Y; Zhang G; Mai H; Han Y; Yang L; Guo S
J Surg Res; 2010 May; 160(2):315-24. PubMed ID: 19524257
[TBL] [Abstract][Full Text] [Related]
7. A more persistent tolerance to islet allografts through bone marrow transplantation in minimal nonmyeloablative conditioning therapy.
Lee BW; Lee JI; Oh SH; Ahn YR; Chae HY; Lee MS; Lee MK; Kim KW
Transplant Proc; 2005 Jun; 37(5):2266-9. PubMed ID: 15964395
[TBL] [Abstract][Full Text] [Related]
8. Induction of chimerism permits low-dose islet grafts in the liver or pancreas to reverse refractory autoimmune diabetes.
Zhang C; Wang M; Racine JJ; Liu H; Lin CL; Nair I; Lau J; Cao YA; Todorov I; Atkinson M; Zeng D
Diabetes; 2010 Sep; 59(9):2228-36. PubMed ID: 20530743
[TBL] [Abstract][Full Text] [Related]
9. New approaches for control of anti-self-reactivity in type 1 diabetes and transplantation of pancreatic islets.
Slavin S; Weiss L; Prighozina T; Gurevitch O; Zhu J; Rabstein I; Gross D
Transplant Proc; 1997 Jun; 29(4):1929-31. PubMed ID: 9193459
[No Abstract] [Full Text] [Related]
10. Increasing donor chimerism and inducing tolerance to islet allografts by post-transplant donor lymphocyte infusion.
Liu B; Hao J; Pan Y; Luo B; Westgard B; Heremans Y; Sutherland DE; Hering BJ; Guo Z
Am J Transplant; 2006 May; 6(5 Pt 1):933-46. PubMed ID: 16611329
[TBL] [Abstract][Full Text] [Related]
11. Mixed allogeneic chimerism in the rat. Donor-specific transplantation tolerance without chronic rejection for primarily vascularized cardiac allografts.
Colson YL; Zadach K; Nalesnik M; Ildstad ST
Transplantation; 1995 Nov; 60(9):971-80. PubMed ID: 7491703
[TBL] [Abstract][Full Text] [Related]
12. MHC-mismatched chimerism is required for induction of transplantation tolerance in autoimmune nonobese diabetic recipients.
Wang M; Racine J; Zhang M; Wu T; Deng R; Johnston H; Shen C; Siswanto K; Zeng D
J Immunol; 2014 Aug; 193(4):2005-15. PubMed ID: 25000982
[TBL] [Abstract][Full Text] [Related]
13. Islet transplantation in Type-I diabetes: current state and prospects.
Mandel TE
Ann Acad Med Singap; 1991 Jul; 20(4):513-8. PubMed ID: 1799266
[TBL] [Abstract][Full Text] [Related]
14. Combined islet and hematopoietic stem cell allotransplantation: a clinical pilot trial to induce chimerism and graft tolerance.
Mineo D; Ricordi C; Xu X; Pileggi A; Garcia-Morales R; Khan A; Baidal DA; Han D; Monroy K; Miller J; Pugliese A; Froud T; Inverardi L; Kenyon NS; Alejandro R
Am J Transplant; 2008 Jun; 8(6):1262-74. PubMed ID: 18444924
[TBL] [Abstract][Full Text] [Related]
15. Tregs and Mixed Chimerism as Approaches for Tolerance Induction in Islet Transplantation.
Pathak S; Meyer EH
Front Immunol; 2020; 11():612737. PubMed ID: 33658995
[TBL] [Abstract][Full Text] [Related]
16. A nonlethal conditioning approach to achieve durable multilineage mixed chimerism and tolerance across major, minor, and hematopoietic histocompatibility barriers.
Colson YL; Wren SM; Schuchert MJ; Patrene KD; Johnson PC; Boggs SS; Ildstad ST
J Immunol; 1995 Nov; 155(9):4179-88. PubMed ID: 7594573
[TBL] [Abstract][Full Text] [Related]
17. Mixed allogeneic chimerism to induce tolerance to solid organ and cellular grafts.
Exner BG; Acholonu IN; Bergheim M; Mueller YM; Ildstad ST
Acta Haematol; 1999; 101(2):78-81. PubMed ID: 10202237
[TBL] [Abstract][Full Text] [Related]
18. Induction of stable long-term mixed hematopoietic chimerism following nonmyeloablative conditioning with T cell-depleting antibodies, cyclophosphamide, and thymic irradiation leads to donor-specific in vitro and in vivo tolerance.
Mapara MY; Pelot M; Zhao G; Swenson K; Pearson D; Sykes M
Biol Blood Marrow Transplant; 2001; 7(12):646-55. PubMed ID: 11787527
[TBL] [Abstract][Full Text] [Related]
19. [Xenotransplantation of islets of Langerhans: a possible therapy for diabetes mellitus?].
Igaz P
Wien Med Wochenschr; 2001; 151(13-14):291-4. PubMed ID: 11582992
[TBL] [Abstract][Full Text] [Related]
20. Injection of bone marrow cells into the thymus to achieve tolerance in an islet xenotransplant (human-to-rat) model.
Dellagiacoma G; Rossi M; Castagna MT; Radin S; Vecchioni R
Transplant Proc; 1994 Jun; 26(3):1114-5. PubMed ID: 8029850
[No Abstract] [Full Text] [Related]
[Next] [New Search]
